Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ENSG00000250424 locus encodes a predicted protein resulting from a readthrough transcriptional event between the *MINDY4* deubiquitinating enzyme gene and the *Aquaporin 1 (AQP1)* water channel gene[2][5]. Readthrough, or transcriptional/ translational continuation from one coding region into another, sometimes produces novel fusion proteins, but such variants are often not well-characterized or may represent artifacts rather than functional proteins. For ENSG00000250424, there is no evidence of physiological relevance, therapeutic targeting, or association with disease. The best-characterized aspects pertain to the parent proteins: MINDY4 acts as a K48-specific deubiquitinase involved in protein turnover; AQP1 mediates water transport across membranes[3][5]. This readthrough gene is not a recognized therapeutic target, and its protein product is likely poorly understood, noncanonical, and may not exist as a biologically significant molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel protein, MINDY4 and Aquaporin 1 readthrough (No standardized abbreviation; ENSG00000250424 is used for locus identification, but not as a canonical protein abbreviation).